NEW YORK, February 14, 2018 /PRNewswire/ —

A report by New Frontier Data in partnership with Arcview Market Research indicates that the legalization of cannabis in California, Massachusetts, Nevada, Florida, Arkansas and North Dakota will result in new markets that will account for $7.1 billion in sales by 2020. The data estimates that the total U.S. cannabis market will surpass $20.9 billion by 2020. By segment, the medical cannabis market was worth $4.7 billion in 2016 and is expected to grow to $13.3 billion by 2025. Recreational cannabis sales during the same period are projected to grow at a 21 percent CAGR, from $1.9 billion to $10.9 billion., Inc. (OTC: CIIX), Medical Marijuana, Inc. (OTC: MJNA), PotNetwork Holding, Inc. (OTC: POTN), CV Sciences, Inc (OTC: CVSI), Freedom Leaf, Inc. (OTC: FRLF)

Among the wide range of products in the cannabis industry, CBD products are in the spotlight. CBD oil is nonpsychoactive and is known for reliefs of pain, anxiety and depression, stimulate appetite and have anti-inflammatory and anti-acne properties. In a report by NY Times, Shereene Idriss, a dermatologist in Manhattan, explained the difference between CBD and hemp products: “CBD lotion that also has THC in it, it’s going to help you much more with pain relief,” she said. “But the ones from hemp, are they going to help as much? It’s hard to tell because we don’t have the data and studies. Also, the problem is you often don’t know how much you are getting – it’s completely unregulated.”, Inc. (OTCQB: CIIX) on February 5th announced that, “Its wholly-owned foreign enterprise CBD Biotechnology Co. Ltd. (‘CBD Biotech’) will launch 4 new hemp infused skin care products and a cutting-edge magnetic mask for the China Market in February 2018. The products have been approved

Read More Here...